2GHG
h-CHK1 complexed with A431994
Summary for 2GHG
| Entry DOI | 10.2210/pdb2ghg/pdb |
| Related | 2AYP 2FGA |
| Descriptor | Serine/threonine-protein kinase Chk1, 5-{5-[(S)-2-AMINO-3-(1H-INDOL-3-YL)-PROPOXYL]-PYRIDIN-3-YL}-3-[1-(1H-PYRROL-2-YL)-METH-(Z)-YLIDENE]-1,3-DIHYDRO-INDOL-2-ONE (3 entities in total) |
| Functional Keywords | protein-inhibitor complex, transferase |
| Biological source | Homo sapiens (human) |
| Cellular location | Nucleus: O14757 |
| Total number of polymer chains | 1 |
| Total formula weight | 31544.28 |
| Authors | Park, C. (deposition date: 2006-03-27, release date: 2007-03-27, Last modification date: 2024-02-14) |
| Primary citation | Zhu, G.D.,Gandhi, V.B.,Gong, J.,Luo, Y.,Liu, X.,Shi, Y.,Guan, R.,Magnone, S.R.,Klinghofer, V.,Johnson, E.F.,Bouska, J.,Shoemaker, A.,Oleksijew, A.,Jarvis, K.,Park, C.,De Jong, R.,Oltersdorf, T.,Li, Q.,Rosenberg, S.H.,Giranda, V.L. Discovery and SAR of oxindole-pyridine-based protein kinase B/Akt inhibitors for treating cancers. Bioorg.Med.Chem.Lett., 16:3424-3429, 2006 Cited by PubMed Abstract: We describe a series of potent and selective oxindole-pyridine-based protein kinase B/Akt inhibitors. The most potent compound 11n in this series demonstrated an IC(50) of 0.17nM against Akt1 and more than 100-fold selectivity over other Akt isozymes. The selectivity against other protein kinases was highly dependent on the C-3 substitutions at the oxindole scaffold, with unsubstituted 9e or 3-furan-2-ylmethylene (11n) more selective and 3-(1H-pyrrol-2-yl)methylene (11f) or 3-(1H-imidazol-2-yl)methylene (11k) less selective. In a mouse xenograft model, 9d, 11f, and 11n inhibited tumor growth but with accompanying toxicity. PubMed: 16644221DOI: 10.1016/j.bmcl.2006.04.005 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (3.5 Å) |
Structure validation
Download full validation report






